# FCPM Sells Dyne But Watch the Milestones

Page: https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/fcpm-sells-dyne-but-watch-the-milestones
Text version: https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/fcpm-sells-dyne-but-watch-the-milestones.md
Podcast: [Business News Today | 2 Min News | The Daily News Now!](https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192)
Published: 2026-05-30T16:55:32+00:00
Episode link: https://api.fastcast.ai/audio/8a101043-1c3f-4a64-98d1-6b5a68b050d5.mp3
Audio file: https://api.fastcast.ai/audio/8a101043-1c3f-4a64-98d1-6b5a68b050d5.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/fcpm-sells-dyne-but-watch-the-milestones
Duration seconds: 130

## Resource

FCPM III Services B.V. just sold nearly 818,000 shares of Dyne Therapeutics for $14.1M — a major move that slashed their stake value by $22M — yet Dyne still anchors 11.8% of their portfolio. With Dyne’s stock up 60% in a year and a major FDA BLA for z-rostudirsen on deck for potential Q1 2027 launch, the company’s momentum is undeniable. They’re also launching a pivotal 72-week Phase III trial (FORZETTO) to confirm efficacy across mobility, lung function, and quality of life — all while advancing other therapies for rare muscular dystrophies. Investors are now watching closely: can Dyne turn regulatory wins into real-world commercial success? Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/c8d1dbdc855b99d5

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/fcpm-sells-dyne-but-watch-the-milestones/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/fcpm-sells-dyne-but-watch-the-milestones.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.